KLF2 inhibits tumor cell growth and migration in hepatocellular carcinoma (HCC), non-small cell lung cancer (NSCLC), and clear cell renal cell carcinoma (ccRCC) [127]. Here, KLF2 is linked to clear cell renal carcinoma.